Patient Support Program

Patient Support Program BREYANZI^®

Supporting you, your patients, and their caregivers throughout the BREYANZI treatment journey

The Patient Support Program for BREYANZI is designed to support patients and caregivers living outside of a given range from their assigned CAR T–qualified treatment centre to ensure necessary proximity
For safety reasons, patients with their caregiver must be close to their treatment centre for a minimum of 4 weeks post infusion in case of adverse events

Travel, lodging, and meal program*

Services offered through the leukapheresis, treatment, and monitoring periods:

Travel from the patient’s home to the CAR T Centre

Coverage offered for the BREYANZI patient and one designated caregiver
For each approved trip, one round trip of transportation services will be covered (organized ground transportation and/or train fare or airfare, depending on the distance travelled)
Patients or their caregivers using their own car will be reimbursed their mileage

Transportation between patient’s lodging site and CAR T Centre

The Program will provide financial support for your patient’s daily commute between their lodging site and the qualified treatment centre

Lodging in proximity to CAR T Centre

Lodging for the BREYANZI patient and one designated caregiver will be covered for the duration of their stay

Meal program

A daily meal allowance for the BREYANZI patient and one designated caregiver throughout the duration of travel

Eligibility requirements:^†

Patient must be a resident of Canada
Patient treatment costs are or will be accepted by a participating jurisdiction
Patient must be enrolled into the Patient Support Program for BREYANZI
Patient lives at least 1.5 hours’ driving distance from the CAR T Centre
Patient travel and accommodation costs are not covered by a jurisdiction (provincial policies may apply)

Have questions? Contact us!

Toll-free phone number: 1-833-397-8332 | Fax number: 1-833-397-8424
Email: breyanzi@bayshore.ca
Monday to Friday: 8:00 a.m.–8:00 p.m., EST

CAR T: chimeric antigen receptor T cell.
* Assistance for lodging is limited only to third-party companies and will not be offered for treatment centre–owned lodging.
† Additional eligibility requirements may apply. Bristol-Myers Squibb reserves the right to rescind, revoke, or amend this program without notice.